Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Medical Food Debut Features MenaQ7 Crystals - Nutraceuticals World
Products & Ingredients

Medical Food Debut Features MenaQ7 Crystals

Primus Pharmaceuticals, Scottsdale, AZ has introduced a new prescription medical food, Fosteum PLUS, featuring Oslo, Norway-based NattoPharma’s MenaQ7 Crystals. The companies report that this is the first medical food product to incorporate vitamin K2, targeting bone health while protecting cardiovascular health. Launched in the U.S. in 2012, this introduction marks MenaQ7’s first inclusion in the prescription therapeutic drug medical market.
 
Fosteum PLUS is for the clinical dietary management of the metabolic processes associated with osteopenia and osteoporosis with MenaQ7 vitamin K2 for improved bone results and cardiac safety. Fosteum Plus can only be used with a physician’s prescription. 
 
Eric Anderson, global vice president of marketing for NattoPharma stated,  “Fosteum PLUS represents a ground-breaking development for bone health, as the inclusion of ultra-high purity; patented MenaQ7 is based on the unique three-year study, published in Osteoporosis International, which demonstrates MenaQ7’s clear preservation of bone constitution and strength in menopausal women.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters